Preclinical and Early Clinical Investigations Related to Monoaminergic Pain Modulation
Open Access
- 1 October 2009
- journal article
- review article
- Published by Elsevier in Neurotherapeutics
- Vol. 6 (4), 703-712
- https://doi.org/10.1016/j.nurt.2009.07.009
Abstract
No abstract availableKeywords
This publication has 122 references indexed in Scilit:
- Contribution of dopamine receptors to periaqueductal gray-mediated antinociceptionPsychopharmacology, 2009
- Pharmacological disruption of calcium channel trafficking by the α 2 δ ligand gabapentinProceedings of the National Academy of Sciences, 2008
- Central serotonergic neurons are differentially required for opioid analgesia but not for morphine tolerance or morphine rewardProceedings of the National Academy of Sciences, 2007
- Spinal α2‐adrenergic and muscarinic receptors and the NO release cascade mediate supraspinally produced effectiveness of gabapentin at decreasing mechanical hypersensitivity in mice after partial nerve injuryBritish Journal of Pharmacology, 2006
- Evidence of a role for descending serotonergic facilitation in a rat model of cancer-induced bone painNeuroscience Letters, 2006
- Therapeutic outcome in neuropathic pain: relationship to evidence of nervous system lesionEuropean Journal of Neurology, 2004
- Peripheral neuropathic pain—a multidimensional burden for patientsEuropean journal of pain, 2001
- Potentiation of Opioid Analgesia by Psychostimulant Drugs: A ReviewJournal of Pain and Symptom Management, 1998
- The american college of rheumatology 1990 criteria for the classification of fibromyalgiaArthritis & Rheumatism, 1990
- Intrathecal serotonin in mice: Analgesia and inhibition of a spinal action of substance PLife Sciences, 1983